USPTO serial 79171662
PLEXUS
Reviewed by CopyMark Law Group
Reg. 5024473Status 706Renewal
- Filing date
- Status date
- Registration date
- Aug 23, 2016
- Examiner
- BOULTON, KELLY F
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PLEXUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan E. Fink
Megan E. Fink Bodman PLC201 South Division Street, Suite 400Ann Arbor, MI 48104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Surgical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease, namely, thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, namely, surgical mesh comprised primarily of prosthetic materials; medical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease; grafts, namely, prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; stents, patches, namely, patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; prostheses, namely, artificial surgical prostheses; surgical implants comprising artificial material; suture materials; patches for repair and reconstruction of internal tissue, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, synthetic heart valve conduits, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; artificial vascular grafts; artificial endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease medical devices for use in endovascular procedures for treating cardiovascular disease; stents; thoracic stents; artificial thoracic stent grafts; thoracic stent graft systems comprising synthetic stent grafts and stent delivery systems; delivery systems for stent graft systems comprising stent delivery systems; aneurysm repair systems comprised of catheter delivered artificial stent grafts and stent delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems comprised of artificial cardiac valves; artificial heart valves; heart valve conduits namely, catheters for implanting heart valves; cardiac patches and vascular patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 28, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 24, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 20, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 20, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 20, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 20, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 23, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Oct 24, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 11, 2022 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 11, 2022 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jun 6, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 21, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 23, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 17, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 19, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 19, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 23, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 23, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 28, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 7, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 1, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 1, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 18, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 30, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 29, 2016 | ALIE | ASSIGNED TO LIE | — |
| Apr 28, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 28, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 28, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 28, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 29, 2016 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 29, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 29, 2016 | ALIE | ASSIGNED TO LIE | — |
| Mar 15, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 15, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 2, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 15, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 15, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 12, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 11, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 4, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |